The use of different strategies affecting these signaling pathways, such as GK activators or a preserved TSC2 activity, could be beneficial for the maintenance of pancreatic β cells for longer periods of time, avoiding its loss in pathologies such as type 2 diabetes mellitus. This evidence concerns the gene TSC2 and diabetes mellitus.